arginyl-glycyl-aspartic acid has been researched along with Fatty Liver in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Busuttil, RW; Coito, AJ; Duarte, S; Fondevila, C; Shen, XD | 1 |
Busuttil, RW; Coito, AJ; Fondevila, C; Moore, C; Shen, XD | 1 |
2 other study(ies) available for arginyl-glycyl-aspartic acid and Fatty Liver
Article | Year |
---|---|
Cytoprotective effects of a cyclic RGD peptide in steatotic liver cold ischemia and reperfusion injury.
Topics: Animals; Blotting, Western; Cold Temperature; Cytoprotection; Disease Models, Animal; Down-Regulation; Fatty Liver; Immunohistochemistry; In Situ Nick-End Labeling; Interferon-gamma; Matrix Metalloproteinase 9; Neutrophils; Nitric Oxide Synthase Type II; Oligopeptides; Rats; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; Survival Rate | 2009 |
Cyclic RGD peptides with high affinity for alpha5beta1 integrin protect genetically fat Zucker rat livers from cold ischemia/reperfusion injury.
Topics: Animals; Fatty Liver; Integrin alpha5beta1; Male; Matrix Metalloproteinase 9; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oligopeptides; Peptides, Cyclic; Rats; Rats, Zucker | 2005 |